Cooley advised Iterum Therapeutics plc on its $80 million initial public offering of 6,150,000 ordinary shares. The underwriters have a 30-day option to purchase up to…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now